Proximal interleukin-10 gene polymorphisms in Italian patients with systemic sclerosis

被引:25
作者
Beretta, L. [1 ]
Cappiello, F. [1 ]
Barili, M. [1 ]
Scorza, R. [1 ]
机构
[1] Univ Milan, Osped Maggiore, Fdn IRCCS,Policlin,Mangiagalli & Regina Elena, Referral Ctr Syst Autoimmune Dis, I-20122 Milan, Italy
来源
TISSUE ANTIGENS | 2007年 / 69卷 / 04期
关键词
interleukin-10; polymorphism; systemic sclerosis;
D O I
10.1111/j.1399-0039.2007.00811.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Interleukin-10 (IL-10) can favour the development of fibrosis by promoting a relative shift towards T helper 2 responses. Three single base pair substitutions in the 5' flanking region of the IL-10 gene (G/A -1082, C/T -819 and C/A -592) influence the amount of IL-10 secreted in cell cultures: the GCC haplotype is associated with an increased production, while the ACC and the ATA haplotypes are associated with intermediate and decreased production. Accordingly, three phenotypes have been individuated: high producers (GCC(+)/GCC(+)), medium producers (GCC(+)/GCC(-)) and low producers (GCC(-)/GCC(-)). We hypothesised that IL-10 haplotypes and genotypes are differently expressed in patients with systemic sclerosis (SSc) with the limited cutaneous SSc (lcSSc) subset or the diffuse cutaneous SSc (dcSSc) subset. One hundred and sixty-one unrelated Italian patients with SSc and 94 controls have been included. Their DNA was extracted and stored before being analysed by polymerase chain reaction with sequence-specific primers. The GCC haplotype is overrepresented in patients with SSc; subjects with dcSSc were the primary contributors to these results (dcSSc: 52.2% vs controls: 37.2%; chi(2) = 8.519, 2 d.f., corrected P = 0.04). In Scl70-positive patients, the GCC haplotype increased the likelihood of presenting the dcSSc subset [chi(2) = 12.56, P < 0.0005; odds ratio (OR) = 3.89, 95% confidence interval (CI95) = 1.69-9.08]; these results were confirmed at the phenotypic level (chi(2) = 11.67, 2 d.f., P = 0.003). In Scl70-positve patients, the high-producing phenotype was associated with poor survival, independently from disease subset and gender (hazard ratio = 9.9, CI95 = 1.6-61.27, P < 0.05). The IL-10 haplotype and genotype associated with high IL-10 production may alter the susceptibility to SSc and/or its expression, increasing the prognostic value of other well-known markers of disease severity.
引用
收藏
页码:305 / 312
页数:8
相关论文
共 39 条
  • [1] Genetics of scleroderma: update on single nucleotide polymorphism analysis and microarrays
    Assassi, S
    Tan, FK
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2005, 17 (06) : 761 - 767
  • [2] The role of IL-4 and IL-12 in the regulation of collagen synthesis by fibroblasts
    Banning, Ursula
    Krutmann, Jean
    Koerholz, Dieter
    [J]. IMMUNOLOGICAL INVESTIGATIONS, 2006, 35 (02) : 199 - 207
  • [3] T-889C IL-1α promoter polymorphism influences the response to oral cyclophosphamide in scleroderma patients with alveolitis
    Beretta, Lorenzo
    Cappiello, Francesca
    Barili, Morena
    Bertolotti, Francesca
    Scorza, Raffaella
    [J]. CLINICAL RHEUMATOLOGY, 2007, 26 (01) : 88 - 91
  • [4] Analysis of the 5′ flanking region of the interleukin 10 gene in patients with systemic sclerosis
    Crilly, A
    Hamilton, J
    Clark, CJ
    Jardine, A
    Madhok, R
    [J]. RHEUMATOLOGY, 2003, 42 (11) : 1295 - 1298
  • [5] DOUVAS A, 1988, LANCET, V2, P475
  • [6] DZIANKOWSKABART.B, 2004, MED SCI MONIT, V10
  • [7] Vascular injury in systemic sclerosis: angiotensin-converting enzyme insertion/deletion polymorphism.
    Fatini C.
    Guiducci S.
    Abbate R.
    Matucci-Cerinic M.
    [J]. Current Rheumatology Reports, 2004, 6 (2) : 149 - 155
  • [8] The interleukin-10 family of cytokines
    Fickenscher, H
    Hör, S
    Küpers, H
    Knappe, A
    Wittmann, S
    Sticht, H
    [J]. TRENDS IN IMMUNOLOGY, 2002, 23 (02) : 89 - 96
  • [9] Circulating levels of soluble CD30 are increased in patients with systemic sclerosis (SSc) and correlate with serological and clinical features of the disease
    Giacomelli, R
    Cipriani, P
    Lattanzio, R
    DiFranco, M
    Locanto, M
    Parzanese, I
    Passacantando, A
    Ciocci, A
    Tonietti, G
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1997, 108 (01) : 42 - 46
  • [10] Evaluation of interleukin 13 polymorphisms in systemic sclerosis
    Granel, Brigitte
    Chevillard, Christophe
    Allanore, Yannick
    Arnaud, Violaine
    Cabantous, Sandrine
    Marquet, Sandrine
    Weiller, Pierre-Jean
    Durand, Jean-Marc
    Harle, Jean-Robert
    Grange, Claire
    Frances, Yves
    Berbis, Philippe
    Gaudart, Jean
    de Micco, Philippe
    Kahan, Andre
    Dessein, Alain
    [J]. IMMUNOGENETICS, 2006, 58 (08) : 693 - 699